Aim & Scope
Vaccination Research (VR) is a peer-reviewed, open-access journal published by Openventio Publishers, dedicated to advancing the science of vaccines and immunization. The journal gives researchers, clinicians and academics a place to share original research, reviews and clinical findings that move the field forward.
Scope
VR welcomes original research articles, review papers, case reports and short communications in areas including, but not limited to:
- Vaccine Design and Development
- Vaccine Immunology and Correlates of Protection
- Adjuvants and Delivery Systems
- Preclinical and Clinical Vaccine Trials
- Vaccine Safety and Pharmacovigilance
- Immunization Programmes and Policy
- Vaccine Efficacy and Effectiveness Studies
- Vaccines for Emerging and Re-emerging Infections
- Therapeutic and Cancer Vaccines
- Veterinary Vaccines
- Vaccine Manufacturing, Storage and Cold Chain
- Vaccine Acceptance, Hesitancy and Health Communication
Peer Review
All submissions undergo double-blind peer review by at least two independent reviewers with relevant subject expertise. The typical time from submission to first editorial decision is 12–14 weeks. See the Peer Review Policy.
Originality
All manuscripts are screened for plagiarism using iThenticate before peer review. See the Plagiarism Policy.
Open Access and Licensing
VR is a fully open-access journal. Authors retain copyright of their work, which is published under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Article Processing Charges
VR applies an Article Processing Charge based on the corresponding author's country income classification and the article type, with full waivers available for authors from low-income countries, cases of financial hardship, and students and early-career researchers. Full details are on the Article Processing Charges page.
